Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Cian Healthcare Ltd (NSE: CHCL), ISIN INE05BN01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
CHCL last traded at ₹37.68 (+1.98%), with a 52-week range of ₹4.72 to ₹37.68 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 95.00%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 32/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.